Holen Sie sich die Stockscreener-App
1.90
1.04%
-0.02
Handel nachbörslich:
1.90
Schlusskurs vom Vortag:
$1.92
Offen:
$1.9398
24-Stunden-Volumen:
22,430
Relative Volume:
0.02
Marktkapitalisierung:
$2.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.73M
KGV:
-0.0233
EPS:
-81.4762
Netto-Cashflow:
$-7.67M
1W Leistung:
-2.31%
1M Leistung:
-9.52%
6M Leistung:
-83.68%
1J Leistung:
-90.35%
1-Tages-Spanne:
$1.8601
$1.99
1-Wochen-Bereich:
$1.82
$2.03
52-Wochen-Spanne:
$1.82
$22.20
Enveric Biosciences Inc Stock (ENVB) Company Profile
Firmenname
Enveric Biosciences Inc
Sektor
Branche
Telefon
239-302-1707
Adresse
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.90 | 2.67M | 0 | -9.73M | -7.67M | -81.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Enveric Biosciences Inc Aktie (ENVB) Neueste Nachrichten
Patterns Watch: Is Enveric Biosciences Inc stock forming a cup and handle2025 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
ENVB SEC FilingsEnveric Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
VIX Spike: Is APREs ROE strong enoughWeekly Stock Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
ENVB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Weekly Trades: Can SUUN sustain earnings growthMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy - microdose.buzz
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent - Investing News Network
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Asianet Newsable
Enveric Biosciences announces withdrawal of PGR petition filed by Gilgamesh Pharmaceuticals against its patent - marketscreener.com
Biopharmaceutical company Enveric Biosciences announced today that Gilgamesh Pharmaceuticals has officially withdrawn its post-grant review request for a patent previously filed against Enveric Biosciences. - Bitget
Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now UncontestedEnveric Biosciences (NASDAQ:ENVB) - Benzinga
Market Review: Does ARIS have declining or rising EPSMarket Movers & Reliable Breakout Forecasts - baoquankhu1.vn
Will Enveric Biosciences Inc. stock outperform Dow Jones index2025 Winners & Losers & Daily Stock Trend Watchlist - mfd.ru
MSN Money - MSN
Enveric Biosciences reports EB-003 receptor engagement assay data - Yahoo Finance
Is Enveric Biosciences Inc.’s ROE strong enoughGDP Growth & Growth Focused Stock Pick Reports - mfd.ru
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data - Investing News Network
Enveric’s lead drug candidate activates key pathways linked to depression relief - Investing.com Canada
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy - microdose.buzz
Enveric Biosciences (ENVB) stock: gains as EB-003 shows dual 5-HT₂A pathway activation - parameter.io
Enveric's EB-003 Assay Data Shows Dual 5-HTA Pathway Engagement; Stock Up - Nasdaq
Enveric Biosciences stock soars after revealing new data on lead drug candidate - Investing.com Australia
Enveric Stock Surges After Licensed Trademark Deal - timothysykes.com
Enveric Biosciences (ENVB) Reveals Promising Data on Lead Candidate EB-003 - GuruFocus
Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals - Benzinga
[EFFECT] Enveric Biosciences, Inc. SEC Filing - Stock Titan
US Market Recap: What makes Enveric Biosciences Inc stock attractive todayJuly 2025 Institutional & Risk Managed Investment Entry Signals - baoquankhu1.vn
What makes Enveric Biosciences Inc. stock attractive to growth funds2025 Technical Patterns & Expert Approved Trade Ideas - mfd.ru
Can Enveric Biosciences Inc. lead its sector in growthQuarterly Risk Review & Comprehensive Market Scan Insights - mfd.ru
Enveric Biosciences Nears Key Clinical Milestone with Novel Drug Candidate - AD HOC NEWS
Enveric Biosciences (ENVB) Files for Share Sale to Investors - GuruFocus
Why Enveric Biosciences Inc. stock remains on buy listsJuly 2025 Snapshot & Pattern Based Trade Signal System - mfd.ru
US Market Wrap: Is PEBK benefiting from innovation trendsMarket Volume Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Enveric Biosciences Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Growth Report: What is Enveric Biosciences Incs book value per shareWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Can Enveric Biosciences Inc sustain its profitabilityJobs Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Analyst Calls: Is Enveric Biosciences Inc a good ESG investmentQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
Fed Meeting: Can Magnite Inc grow without external fundingJuly 2025 Reactions & Verified Momentum Watchlists - baoquankhu1.vn
Enveric Biosciences registers $1.35 million in new shares under ATM agreement - Investing.com UK
Enveric Biosciences registers $1.35 million in new shares under ATM agreement By Investing.com - Investing.com India
Enveric Biosciences Registers Additional Shares for ATM Offering - TradingView
Enveric Biosciences (NASDAQ:ENVB) Trading Down 7.4% – Should You Sell? - Defense World
How does Enveric Biosciences Inc. score in quality rankingsAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric licenses RCANN trademark portfolio to TOTEC Pharma By Investing.com - Investing.com South Africa
Enveric Biosciences (ENVB) Licenses Trademark Portfolio to Totec Pharma - GuruFocus
Enveric Biosciences closes $1.5 million registered direct offering By Investing.com - Investing.com Australia
Is Enveric Biosciences Inc. being accumulated by smart money2025 Earnings Impact & Daily Technical Stock Forecast Reports - mfd.ru
Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):